DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epidermal growth factor in the topical treatment of herpetic corneal ulcers.

Author(s): Cellini M, Baldi A, Caramazza N, De Felice GP, Gazzaniga A

Affiliation(s): Institute of Ophthalmology, University of Bologna, Italy.

Publication date & source: 1994, Ophthalmologica., 208(1):37-40.

Publication type: Clinical Trial; Randomized Controlled Trial

The tolerability and efficacy of epidermal growth factor (EGF) in the topical treatment of herpetic corneal ulcers in addition to topical acyclovir have been evaluated in a double-blind, placebo-controlled, randomized study in two groups of patients. The time required for complete reepithelialization of the cornea was recorded, and the data obtained were analyzed statistically. In the EGF group, the reepithelialization was significantly faster than in the control group. Tolerability of EGF was always excellent. These results indicate that EGF is safe and effective in reducing the healing time of herpetic corneal ulcers.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017